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 25 
ABSTRACT  26 
This study aimed at characterising the fatty acid (FA) composition of red blood cell 27 
(RBC) phospholipids in children and adolescents with primary hyperlipidemia, and to 28 
ascertain potential association with serum lipid profile and dietary factors. At this 29 
purpose, 54 probands aged 6-17 years were recruited. Subjects showed a low omega-3 30 
index (eicosapentaenoic acid, EPA + docosahexaenoic acid, DHA<4%). Compared to 31 
males, females had a trend towards lower levels of total monounsaturated fatty acids 32 
(MUFA) and MUFA/saturated fatty acids (SFAs) ratio in RBCs. An inverse relationship 33 
between MUFA concentration in RBCs and serum cholesterol or HDL-C/triglycerides 34 
ratio was found. Omega-6 polyunsaturated fatty acids (n-6 PUFA) were positively 35 
associated to serum HDL-C levels, and inversely to dietary cholesterol. Fibre intake was 36 
positively associated with MUFA/SFA ratio. In conclusion, we provide the first 37 
experimental data on phospholipid FA composition of RBCs in hyperlipidemic children, 38 
showing sex differences and an overall low omega 3-index.  39 
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Introduction 40 
Hyperlipidemias are disorders of lipoprotein metabolism characterized by an increase in 41 
serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), or 42 
triglycerides (TG). These disorders, both primary (monogenic and polygenic inherited 43 
forms) and secondary (related to other diseases) forms, are considered a major cause of 44 
atherosclerosis and cardiovascular disease (CVD) (Newman et al. 1986; Ahmed et al. 45 
1998; Groner et al. 2006; Haney et al. 2007). 46 
The atherosclerotic process begins early in life, thus children and adolescents 47 
affected by primary hyperlipidemia show a particularly high risk to develop CVD later 48 
in life (Durrington 2003), which is mainly secondary to chronic exposure to elevated 49 
LDL-C, accumulating in the intima-media of large muscular arteries (Durrington 2003; 50 
McGill et al. 2000). Healthy lifestyle, which includes appropriate dietary pattern in 51 
agreement with the expert panel guidelines for CV health and risk reduction in children 52 
and adolescents (Expert panel …, 2011), physical activity and weight loss in case of 53 
excessive body weight, is the cornerstone in the treatment of hyperlipidemia and 54 
represents an important target for CVD prevention (Haney et al. 2007; Catapano et al. 55 
2011). It has been suggested that the lipid composition of RBC membranes can be 56 
considered as an additional risk factor in the progression of atherosclerosis and coronary 57 
heart disease (Lausada et al. 2007; Tziakas et al. 2010). The fatty acid (FA) composition 58 
of red blood cells (RBCs) generally reflects the last three months of dietary fat intake, 59 
and it is thought to be a biomarker of the tissue fatty acid status (Sarkkinen et al. 1994; 60 
Kuratko et al. 2009; Brigandi et al. 2015).  61 
Since erythrocytes are incapable of de novo phospholipid synthesis, chain elongation 62 
or desaturation of fatty acids, the major pathway to renew the RBC phospholipids is the 63 
direct exchange from plasma lipoproteins to the erythrocyte (Marks et al. 1960; 64 
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Farquhar & Ahrens 1963; Reed 1968; Hodson et al. 2008). Thus, the RBC FA 65 
composition is postulated to better and earlier reflect the pathology of lipid metabolism, 66 
in respect to lipoprotein changes in blood serum, which are affected by recent food 67 
consumption (Sarkkinen et al. 1994; Harris & Von Schacky 2004; Novgorodtseva et al. 68 
2011).  69 
Studies conducted in adults found a correlation between altered FA composition in 70 
RBCs and coronary heart disease, arterial hypertension, dyslipidemia and other 71 
atherosclerosis-related diseases (Engelmann et al. 1992; Taylor 1994; Antoku et al. 72 
2000; Lausada et al. 2007; Vayá et al. 2009; Ristic-Medic et al. 2009; Tziakas et al. 73 
2010; Novgorodtseva et al. 2011; Jacobs et al. 2014). Harris & Von Schacky (2004) 74 
demonstrated that a low content of eicosapentaenoic (EPA) and docosahexaenoic 75 
(DHA) acids in the RBC membranes is strongly associated with coronary hearth 76 
diseases. The total levels of EPA and DHA in RBCs, defined as omega-3 index, was 77 
suggested as an additional biomarker of CV risk, and a predictive parameter for 78 
morbidity and mortality from CVD (Harris & Von Schacky 2004). Since most of this 79 
class of compounds is contained in cell membranes, the index has been also calculated 80 
on RBC phospholipids and other cell types; moreover, comparison with data obtained in 81 
plasma has been performed (Harris & Thomas 2010; Rice et al. 2016). 82 
Despite the potential impact of knowing the RBC membrane FA composition in 83 
patients affected by lipoprotein disorders in terms of risk prediction, studies are still 84 
limited and mainly performed in adults. In this regard, trials carried out in children were 85 
mainly aimed at characterizing the phospholipid FAs of RBCs in healthy subjects 86 
(Laryea et al. 1990; Jakobit et al. 2009; Cortés et al. 2012), or in patients affected by 87 
other diseases (Decsi et al. 2002; Vanderjagt et al. 2003; Trebbe et al. 2003; Chen et al. 88 
2004; Bu et al. 2006; Vaisman et al. 2008; Burrows et al. 2011; Perona et al. 2013; 89 
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Brigandi et al. 2015; Bueno et al. 2015). Furthermore, data on gender difference in RBC 90 
composition in childhood and adolescence have not been adequately investigated. 91 
The aim of the present study is to provide data on the RBC phospholipid FA 92 
composition in a population of Italian children and adolescents with primary 93 
hyperlipidemia, receiving medical nutrition therapy at least 6 months before the 94 
recruitment. Since RBC phospholipid FA composition is influenced by blood 95 
lipoprotein profile/concentration changes and diet we also investigated the association 96 
with serum biomarkers and dietary parameters.  97 
 98 
Materials and methods 99 
Subject enrolment and study design 100 
Fifty-four children and adolescents with primary hyperlipidemia were recruited among 101 
pediatric patients cared at the Department of Health Science and Pediatrics of the 102 
University of Turin, after a screening for eligibility. Children and adolescents included 103 
in the study were 6-17 years old, affected by familial hypercholesterolemia (FH), 104 
familial combined hyperlipidemia (FCHL) or polygenic hypercholesterolemia (PHC). 105 
Exclusion criteria were: secondary dyslipidemia; obesity (body mass index (BMI) ≥ 90th 106 
percentile, age and sex matched); renal, endocrine and liver disorders; or chronic 107 
diseases requiring drug treatment (i.e. immunologic, neurologic, or oncohematologic 108 
disorders). Participants were not on lipid-lowering treatments (including functional 109 
foods) in the previous 3 months and were not smoking. Children on diet therapy were 110 
selected after demonstrating appropriate compliance with dietary instructions, provided 111 
by a trained nutritionist, in the previous 2 months. Recruited subjects and their families 112 
were trained by a nutritionist to adhere to a properly dietary regimen, evaluated by a 113 
weekly food diary. 114 
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Diagnostic criteria of familial hyperlipidemia were based on accepted international 115 
standards (Guardamagna et al. 2011). FH was diagnosed in presence of LDL-C ≥ 95th 116 
percentile, parental LDL-C ≥ 190 mg/dL, tendon xanthomas and/ or cardiovascular 117 
disease (phenotype IIA). FCHL was diagnosed in children showing TC and/or TG >90th 118 
age- and sex-specific percentile, with at least one parent affected by 119 
hypercholesterolemia, hypertriglyceridemia, or both (IIA, IV, or IIB phenotype, 120 
respectively), with concomitant individual and familial lipid phenotype variability. 121 
Children with LDL-C levels >90th percentile and a family history of dominant inherited 122 
hypercholesterolemia, but not fulfilling the biochemical international diagnostic criteria 123 
of FH or FCHL were diagnosed with PHC.  124 
All subjects enrolled underwent a medical examination in the morning between 8 and 125 
10 a.m. on the day of recruitment. Physical parameters including height, weight and 126 
blood pressure were measured. Height and weight were measured to the nearest 0.1 cm 127 
and 0.1 kg respectively (Wunder SA.BI. S.r.l. Italy), with the patients wearing hospital 128 
gowns and had bare feet. BMI was calculated as body weight in kilograms divided by 129 
height squared in meters (kg/m2). Systolic and diastolic blood pressure was measured 130 
with a mercury sphygmomanometer during the medical examination. Fasting blood 131 
samples were drawn by venipuncture for the analysis of the lipid profile and the FA 132 
composition of RBCs. 133 
Children and their parents had received dietary recommendations based on the 134 
cardiovascular health integrated lifestyle diet (CHILD-1) for children with identified 135 
dyslipidemia, as in the American Academy of Pediatrics (Expert panel …, 2011). The 136 
essential features were: 55% of daily energy from carbohydrate, 15% from protein, 25-137 
30% from total fat (saturated fat <10%, MUFA and PUFA 20% of total energy), dietary 138 
cholesterol <100 mg/1000 kcal and no more than 200 mg/day, and 10-25 g/day of 139 
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soluble fibre. In order to examine correct dietary habits, parents of the enrolled children, 140 
and probands themselves, were asked to fill in a weekly food diary to be provided at 141 
time of the visit. Detailed instructions on how to collect diet records were 142 
comprehensively explained by a nutritionist. The nutritional evaluation of 143 
macronutrients and FA content of the diet registered was performed with MètaDieta® 144 
Software using the Italian Food Composition Tables (Carnovale & Marletta 2000). 145 
The study protocol complied with the principles of the Declaration of Helsinki, and 146 
was approved by the ethics committee of the City of Health and Science University 147 
Hospital of Turin (EC:CS377). The protocol and the purpose of the study were carefully 148 
explained to the participants and to their parents; a written informed consent was 149 
obtained from children’s parents before enrolment in the study.  150 
 151 
Blood sample collection and separation 152 
Venous blood samples of 2.5 ml were drawn into vacutainer tubes containing lithium 153 
heparin (to obtain plasma and RBCs) or silicon (to obtain serum). Plasma and serum 154 
were separated by centrifugation at 1400 g for 15 min at 4°C. Plasma was stored at -155 
80°C for further analysis, while serum was immediately analysed. The buffy layer of 156 
white blood cells was removed using a pipette, and RBCs were washed twice in an 157 
equal volume of a physiologic solution (0.9% NaCl, w/v). Two aliquots (0.5 ml) of 158 
RBCs were stored at -80°C until the analysis. 159 
 160 
Serum lipid profile 161 
Serum levels of TC, HDL-C and TG were directly determined by an automatic 162 
biochemical analyzer (Olympus AU2700, Japan), while the LDL-C concentration was 163 
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estimated using the Friedewald formula (LDL= TC-(HDL+TG/5). Non-high density 164 
lipoprotein cholesterol (non–HDL-C) was calculated as TC minus HDL-C. 165 
Analysis of FA composition of RBC phospholipids  166 
Extraction of RBC phospholipids was performed in accordance to the method 167 
previously described by Simonetti et al. (2002). Briefly, 1 ml of distilled water, 300 mg 168 
of RBC, 2.5 ml of butylated hydroxitoluene (110 µg/ml in methanol), and 5 ml of 169 
chloroform were transferred into 10 ml plastic tubes. The mixtures were shaken on 170 
vortex for 3 min and centrifuged at 1200 g x for 10 min. The chloroform phase was 171 
transferred into 10 ml plastic tubes. An aliquot of 2.5 ml chloroform was added to the 172 
tubes containing RBCs to perform the second extraction by vortexing for 3 min, and, 173 
after centrifugation at 1200 g x for 10 min, the supernatant was transferred into the 174 
corresponding tube. The chloroform phase was eluted on a silica cartridge (Sep-Pack 175 
PlusSilica, Waters), which was then evaporated under nitrogen steam. The silica phase 176 
was transferred into Pyrex glass tubes, and 2.5 ml of a toluene/methanol (1:4 v/v) 177 
mixture and 200 µl of acetyl chloride were added. After 1 h in an oven at 100°C, 5 ml 178 
of K2CO3 (6% w/v in water) was added to the silica. After centrifugation at 1200 g x 10 179 
min, the supernatant was transferred into amber glass vials, dried under nitrogen and 180 
resuspended in 100 µl of hexane before gas chromatography analysis. 181 
The gas chromatography analysis was performed as described by Ackman (1986), 182 
partly modified. Separations were performed with a 30 m 0.32 mm i.d. Omegawax 320 183 
capillary column, under these conditions: initial isotherm, 140 °C for 5 min; 184 
temperature gradient, 2 °C/min to 210°C; final isotherm, 210°C for 20 min. The injector 185 
temperature was 250°C. Injection volume was 1 µl with a split ratio of 1/100, and the 186 
flame ionization detector temperature was 250°C. Carrier and makeup gas were 187 
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hydrogen and nitrogen, respectively. Fatty acid retention times were obtained by 188 
injecting the Omegawax test mix as standard. 189 
Statistical analysis 190 
Statistical analysis was carried out by R statistic software (version 3.1.2). One way 191 
repeated-measures analysis of variance (ANOVA) was used to compare the data 192 
obtained from subjects stratified by sex and by type of hyperlipidemia; post-hoc 193 
analysis of differences between paired data was assessed, when appropriate, by the 194 
Least Significant Difference. Differences in serum lipid concentrations, anthropometric 195 
data and the proportion of FA composition of RBCs in relation to different lipid 196 
disorders was evaluated by non-parametric Wilcoxon-Mann-Whitney test with 197 
Benjamini-Hochberg correction. The relationship among variables was assessed by 198 
Kendall and Spearman rank, non-parametric correlation tests. This approach was used 199 
to achieve the significance level and the trend (direct or inverse) of the data correlation. 200 
The level of statistical significance was set at p<0.05; data are presented as a mean and 201 
standard deviation (SD). 202 
 203 
Results 204 
Subjects characteristics  205 
The main features of the study sample are summarized in Table 1. The cohort of 206 
children and adolescents included 54 hyperlipidemic subjects (26 F), aged 6-17 years 207 
old; 14 were affected by FH (7 F), 21 by FCHL (12 F) and 19 by PHC (7 F). Five 208 
subjects were slightly overweight; mean blood pressure levels were in the normal range.  209 
 210 
Serum lipid profile and RBC phospholipid composition  211 
Serum lipid profile and RBC phospholipid composition of the patients, are reported in 212 
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Table 2, and classified according to gender and clinical diagnosis. Mean serum lipid 213 
parameters exceeded the 90th percentiles (age and sex related), except for HDL-C, 214 
showing normal concentrations. RBC phospholipid composition was 215 
SFA>PUFA>MUFA, with low omega-3 index value (3.76 ± 1.04%).  216 
No significant serum lipid concentration difference was observed between males and 217 
females, while it was detected in the phospholipid composition of RBCs, as females 218 
showed higher concentrations of stearic acid but lower DGLA concentration (p= 0.031 219 
and 0.050, respectively). Moreover, MUFA content and MUFA/SFAs ratio in RBCs 220 
was lower in females than males (p= 0.052 and 0.056, respectively). 221 
A further analysis considering the type of hyperlipidemia revealed that children with 222 
FH had higher levels (p< 0.001) of serum TC, LDL-C and non-HDL-C, and lower 223 
serum HDL/LDL ratio if compared to children with FCHL or PHC. Finally, 224 
significantly lower levels of vaccenic acid and γ-linolenic acid were detected in FH as 225 
compared to PHC children (p= 0.036 and 0.027, respectively). 226 
 227 
Correlation between RBC phospholipid composition and serum lipid profile 228 
Correlations between serum lipid levels and RBC phospholipid composition are 229 
reported in Table 3. Lower RBC MUFA levels correlated with higher serum TC levels 230 
(p= 0.032) and HDL/TG ratio (p= 0.025), but lower serum TG levels (p= 0.005). A 231 
positive correlation between serum HDL-C and PUFA n-6 levels (p= 0.048) was also 232 
detected. 233 
 234 
Food diary analysis and correlation between dietary factors, RBC phospholipid 235 
FAs and serum lipid profile  236 
Complete and detailed weekly food diaries were obtained from 23 (7 F) out of 54 237 
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children, and were used to calculate mean daily energy and macronutrient intake. 238 
Results showed a mean daily total energy intake of 1208 ± 151 kcal suggesting a 239 
possible overall underestimation of food intake (e.g. in terms of portion size declared). 240 
Macronutrients distribution, expressed as percentage of daily energy intake, was: 16.7 ± 241 
2.8% protein, 58.6 ± 6.1% carbohydrate and 24.7 ± 6.4% fat (saturated: 7.4 ± 2.1 %, 242 
monounsaturated: 10.3 ± 4.8 %, polyunsaturated: 2.6 ± 0.5 %). Estimated cholesterol 243 
intake was 136.2 ± 47.2 mg/day, while fibre intake was 14.0 ± 5.3 g/day, confirming 244 
previous data (Guardamagna et al. 2013; Guardamagna et al. 2014). Correlations 245 
between dietary factors, the RBC phospholipid composition and serum lipid profile are 246 
reported in Table 4. An inverse association was found between the dietary intake of 247 
cholesterol and n-6 PUFA and n-6 LC-PUFA levels in RBC phospholipids (p= 0.001 248 
and 0.017, respectively). The fibre intake was directly associated with RBC 249 
MUFA/SFA ratio (p= 0.035). 250 
 251 
Discussion 252 
To our knowledge, this is the first study aimed at characterizing the FA composition of 253 
RBC phospholipids in a population of Italian children and adolescents with primary 254 
hyperlipidemia. 255 
The phospholipid composition of RBCs has been suggested as an additional marker 256 
to monitor serum lipoprotein profile changes (Harris et al. 2004; Novgorodtseva et al. 257 
2001) and as an outcome parameter in the management of hyperlipidemia, although no 258 
reference values exist neither for healthy nor hyperlipidemic adults or children. 259 
Alterations of the erythrocyte lipid matrix have been demonstrated in studies performed 260 
in adults affected by dyslipidemia and/or with risk factors for coronary heart diseases 261 
(Laryea et al. 1990; Engelmann et al. 1992; Taylor 1994; Antoku et al. 2000; Lausada et 262 
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al. 2007; Vajá et al. 2009; Restic-Medic et al. 2009; Novgorodtseva et al. 2011; Jacobs 263 
et al. 2014). For instance, Novgorodtseva et al. (2011) described reduced levels of n-3 264 
PUFA, in particular docosapentaenoic acid (22:5n-3) and DHA (22:6n-3), in 265 
dyslipidemic patients as compared to normal subjects. Lausada et al. (2007) 266 
documented a PUFA decrease and SFA concentrations increase in plasma and RBC 267 
membranes of patients with coronary heart disease, as compared to controls. 268 
Similar studies have been performed in children with diabetes, attention-deficit 269 
hyperactive disorder, autism, and other various disorders, except for hyperlipidemia, 270 
thus, making the comparison of our data with other data from literature extremely 271 
difficult (Decsi et al. 2002; Vanderjagt et al. 2003; Trebbe et al. 2003; Chen et al. 2004; 272 
Bu et al. 2006; Vaisman et al. 2008; Burrows et al. 2011; Perona et al. 2013; Brigandi et 273 
al. 2015; Bueno et al. 2015). Results obtained in subjects with disorders seem to differ 274 
from those obtained in the relative controls. As an example, Perona et al. (2013) found 275 
higher levels of SFAs, and reduced concentrations of MUFAs and n-6 PUFAs in RBC 276 
membranes of obese adolescents as compared to normal weight controls. These results 277 
are in line with our observations as hyperlipidemic children and adolescents showed 278 
comparable SFA and MUFA levels. However, it should be also underlined that values 279 
obtained in different studies and different countries can be significantly affected by the 280 
dietary habits, thus direct comparison of results is not always possible. 281 
It is recognized that children affected by hyperlipidemia exhibit an increased risk of 282 
atherosclerosis and CVD during adulthood (McGill et al. 2000; Durrington 2003). 283 
Recently, the PANIC study evaluated the association between plasma FA composition 284 
(in triacylglycerol and phospholipid fractions), the estimated desaturase/elongase 285 
activities and the cardiometabolic risk in 384 children (Venäläinen et al. 2016). Authors 286 
found a significant positive correlation between FAs metabolism and the 287 
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cardiometabolic risk score for the pediatric population.  288 
The omega-3 index may represent a novel, physiologically relevant and graded risk 289 
factor to predict CVD development, thus having a significant clinical utility. A low 290 
index (≤4%) was associated with a high risk of mortality for CVD and a value ≥8% was 291 
suggested as a reasonable preliminary target for reducing the risk (Harris & Von 292 
Schacky 2004; Von Schacky 2010). In the pediatric population, only one other study 293 
examined the omega-3 index and concluded that a greater proportion of obese children 294 
had a lower index compared with non-obese children (Burrows et al. 2011). In our 295 
study, we documented mean omega-3 index <4% in hyperlipidemic children, a factor 296 
that contribute to classify them as at future high risk for CVD. Since EPA and DHA 297 
derive from essential fatty acids, these results suggest that there is a reduced synthesis 298 
or patients did not regularly consume LC-PUFA rich food sources. In this regard, the 299 
use of whole dietary strategies and/or specific supplementations (e.g. with PUFA, 300 
MUFA or other food bioactives) could be fundamental to improve this index above all 301 
in at risk subjects such as hyperlipidemic children. 302 
The present analysis on sex-related differences showed that females had a 303 
significantly greater proportion of the SFA stearic acid, and lower proportion of n-6 304 
PUFA, in particular DGLA. Lower DGLA values were also observed in serum 305 
glycerophospholipids of healthy young girls when compared with boys (Glaser et al. 306 
2010). Moreover, in females we found a trend towards lower level of MUFA and 307 
MUFA/SFA ratio in RBCs with respect to males. Venäläinen et al. (2016) reported that 308 
a higher plasma level of SFA myristic acid, MUFA palmitoleic acid and reduced 309 
concentrations of n-6 PUFA (linoleic acid) have been correlated with increased 310 
cardiometabolic risk in children. Furthermore, higher levels of stearic, palmitic acids 311 
and lower levels of linoleic acid in RBC membranes were observed in obese adolescents 312 
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(Perona et al. 2013) and in hypercholesterolemic adults (Taylor 1994), as compared to 313 
healthy controls. Both sex and gender differences in the pathogenesis, progression and 314 
manifestation of atherosclerosis and CVD have been well documented for adults (Maas 315 
& Appelman 2010; Mosca et al. 2011; Spence & Pilote 2015), while controversial data 316 
have been reported in children (Marelli et al., 2010; Krishnan et al., 2012). In this 317 
context, our preliminary findings on sex differences in the pediatric population, 318 
associated with higher risk of future coronary diseases, in terms of lipid profile and 319 
CVD risks, could be considered by future studies in this field. 320 
Children affected by FH had significantly lower levels of MUFA, vaccenic acid and 321 
n-6 PUFA γ-linolenic acid in RBCs, with respect to FCH or PCH patients. These data 322 
are consistent with earlier findings in adults demonstrating that subjects with 323 
hypercholesterolemia and advanced coronary heart disease exhibited a decreased PUFA 324 
level and an increased cholesterol and SFA concentrations in erythrocytes related to the 325 
atherosclerotic condition (Taylor 1994; Lausada et al. 2007; Vayá et al. 2009; 326 
Novgorodtseva et al. 2011). As far as the pediatric age is concerned, a significantly 327 
lower level of vaccenic acid in RBCs was also found in diabetic children, as compared 328 
to controls (Decsi et al. 2002).  329 
Correlation analysis performed on the whole study sample (n= 54) showed a positive 330 
association between the n-6 PUFA levels in RBCs and serum HDL-C concentrations, 331 
which was similar to other observations in young or adults, showing a direct 332 
relationship between serum n-6 PUFAs and HDL-C (Ferrucci et al. 2006; Motoyama et 333 
al. 2009; Jelenkovic et al. 2014). Furthermore, we observed an inverse correlation 334 
between MUFA in RBCs and serum TC concentration and HDL/TG ratio. These results 335 
are in agreement with those from previous clinical studies showing that diet rich in 336 
MUFA have potential hypocholesterolemic effect (Yu et al. 1995; Gill et al. 2003; 337 
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Fernandez et al. 2005; Mukuddem-Peterson et al. 2005). In addition, we found a direct 338 
correlation between MUFA in RBCs and serum TG. These results are in line with a 339 
study conducted in two cohorts of young healthy twins, in which the contribution of 340 
genetic and environmental factors at the bases of relationship between FAs and 341 
lipoprotein profile have been performed. Results obtained demonstrated the importance 342 
of common genetic factors in determining the phenotypic covariation of n-6 PUFAs and 343 
MUFAs with TG and VLDL particles (Jelenkovic et al., 2014). The role of metabolic 344 
features and genetic factors on lipid profile is widely studied (Xiang et al. 2007; 345 
Matthan et al. 2014; Mayneris-Perxachs et al. 2014; Tosi et al. 2014). For example, 346 
recent evidences indicate that FA desaturases play an important role in defining blood 347 
and tissue lipid profiles. Polymorphisms in the FA desaturase genes FADS1 and 348 
FADS2, that encode respectively for the delta-5 and delta-6 desaturases, have been 349 
associated with PUFA levels in both serum phospholipids and RBC membranes 350 
(Schaeffer et al. 2006; Malerba et al. 2008; Tosi et al. 2014). Since diet could have also 351 
contributed, we tried to correlate dietary factors with lipid profile in both serum and 352 
RBCs. A correlation between low intake of dietary cholesterol and high level of n-6 353 
PUFA and n-6 LC-PUFA in RBCs was found. In addition, the fibre intake was directly 354 
associated with the MUFA/SFA ratio. These associations have been obtained on a 355 
subgroup of children/adolescents involved (23 out of the 54 subjects) and this can 356 
represent a possible limitation of the study. However, these results provide additional 357 
evidence supporting that a low-cholesterol and fibre-rich diet could contribute to a more 358 
favourable RBC phospholipid FA composition in hyperlipidemic children.  359 
Finally, although a limitation of the study is the absence of a normolipidemic control 360 
group, our data provides for the first time information about the phospholipid 361 
composition of RBCs in a relatively large population of Italian hyperlipidemic children 362 
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and adolescents. 363 
 364 
Conclusion 365 
In conclusion, although preliminary, we provided experimental evidence about 366 
differences in the phospholipid composition of RBCs according to patient type of 367 
hyperlipidemia and sex. The low omega-3 index, evaluated on phospholipid RBCs, 368 
observed in these children confirms the importance of the quality of dietary FAs intake, 369 
particularly in those with primary hyperlipidemia. Further studies should be performed 370 
in order to clarify the RBC phospholipid composition differences between 371 
hyperlipidemic and normolipidemic children, as well as in relation to sex and diagnosis. 372 
Moreover, it would be interesting to study the contribution of specific dietary 373 
interventions/regimen on these parameters in children affected by primary 374 
hyperlipidemia.  375 
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Table 1. Subject characteristics (n= 54) 
Parameter  Value 
Age, years (range) 11 ± 3 (6-17) 
Sex, M/F 28/26 
Weight, kg 47.9 ± 16.4 
Height, cm 149.1 ± 16.1 
BMI, kg/m
2
 20.9 ± 4.0 
Systolic blood pressure, mmHg 104.5 ± 10.1 
Diastolic blood pressure, mmHg 66.6 ± 7.4 
Notes: BMI, body mass index. Values are reported as mean ± SD. 
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Table 2. Serum lipid concentrations and RBC phospholipid FAs composition in hyperlipidemic children and adolescents (n= 54), according to 
sex and type of hyperlipidemia  
Lipid profile 
All subjects 
 
Sex 
 Dyslipidemia 
  
Male  Female  
p-value  
FH FCHL PHC 
p-value 
n= 54   n= 28 n= 26   n=14 n= 21 n= 19 
Serum lipids (mg/dl)     
TC  232.4 ± 55.6  
226.0 ± 56.7 239.2 ± 54.8 0.385 
 
288.2 ± 67.1
a
 214.2 ± 38.3
b
 211.4 ± 30.8
b
 < 0.001 
TG  90.9 ± 51.9  
94.0 ± 53.4 84.9 ± 50.3 0.658 
 
73.6 ± 31.3 102.3 ± 67.6 91.1 ± 42.1 0.282 
HDL-C  58.8 ± 15.4  
58.6 ± 15.6 60.2 ± 14.6 0.912 
 
55.0 ± 10.6 57.8 ± 19.6 62.7 ± 12.7 0.340 
LDL-C  156.3 ± 58.4  
149.1 ± 60.9 163.3 ± 56.8 0.355 
 
219.9 ± 69.5
a
 137.3 ± 36.5
b
 130.3 ± 28.0
b
 < 0.001 
HDL/LDL ratio 0.4 ± 0.2  
0.4 ± 0.2 0.4 ± 0.2 0.502 
 
0.3 ± 0.1
a
 0.5 ± 0.2
b
 0.5 ± 0.2
b
 < 0.001 
HDL/TG ratio 0.9 ± 0.5  
0.8 ± 0.5 0.9 ± 0.5 0.537 
 
0.9 ± 0.5 0.8 ± 0.5 0.8 ± 0.4 0.812 
Non-HDL-C 173.6 ± 59.4  
167.4 ± 61.7 179.0 ± 58.1 0.433 
 
233.2 ± 71.0
a
 156.5 ± 42.5
b
 148.6 ± 31.4
b
 < 0.001 
          
RBC phospholipid FAs (%) 
Total SFAs 48.99 ± 2.23  48.66 ± 2.51 
49.44 ± 1.84 0.261 
 
49.23 ± 2.87 49.35 ± 1.53 48.43 ± 2.35 0.389 
Total MUFAs 18.45 ± 0.91  18.68 ± 0.84 
18.12 ± 0.87 0.052 
 
18.07 ± 0.77 18.59 ± 0.86 18.58 ± 1.02 0.197 
Total PUFAs 32.55 ± 2.14  32.65 ± 2.55 
32.44 ± 1.67 0.729 32.70 ± 2.81 32.06 ± 1.61 32.99 ± 2.10 0.383 
MUFAs/SFAs ratio 0.38 ± 0.03  0.39 ± 0.03 
0.37 ± 0.03 0.056 0.37 ± 0.03 0.38 ± 0.02 0.39 ± 0.03 0.296 
PUFAs/SFAs ratio 0.67 ± 0.08  0.68 ± 0.09 
0.66 ± 0.06 0.452 0.67 ± 0.11 0.65 ± 0.05 0.68 ± 0.08 0.391 
PUFAs n-3/n-6 0.19 ± 0.06  
0.18 ± 0.03 0.20 ± 0.05 0.758 
 
0.19 ± 0.05 0.20 ± 0.07 0.19 ± 0.04 0.871 
LC-PUFAs n-3/n-6 0.33 ± 0.09  
0.31 ± 0.05 0.34 ± 0.09 0.633 
 
0.33 ± 0.09 0.34 ± 0.11 0.32 ± 0.08 0.822 
Omega-3 index  3.76 ± 1.04  
3.54 ± 0.55 3.80 ± 1.08 0.770 3.81 ± 0.87 3.84 ± 1.24 3.62 ± 0.95 0.789 
     
Saturated      
14:0 (myristic acid) 0.41 ± 0.08  
0.40 ± 0.09 0.42 ± 0.08 0.336 
 
0.42 ± 0.10 0.4 ± 0.07 0.4 ± 0.08 0.789 
15:0 (pentadecanoic acid) 0.16 ± 0.03  
0.16 ± 0.03 0.17 ± 0.03 0.152 
 
0.16 ± 0.03 0.16 ± 0.02 0.16 ± 0.03 0.963 
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16:0 (palmitic acid) 24.05 ± 1.38  
24.02 ± 1.52 24.08 ± 1.23 0.864 24.4 ± 1.56 24.06 ± 1.10 23.78 ± 1.52 0.625 
17:0 (margaric acid) 0.46 ± 0.17  
0.46 ± 0.16 0.45 ± 0.19 0.803 0.42 ± 0.22 0.44 ± 0.19 0.51 ± 0.11 0.387 
18:0 (stearic acid) 15.47 ± 1.47  
15.06 ± 1.40
a
 15.92 ± 1.44
b
 0.031 15.61 ± 2.10 15.68 ± 1.16 15.15 ±  1.24 0.593 
20:0 (arachidic acid) 0.56 ± 0.15  
0.58 ± 0.20 0.55 ± 0.05 0.579 0.54 ± 0.07 0.55 ± 0.05 0.6 ±  0.23 0.610 
22:0 (behenic acid) 1.99 ± 0.28  
1.98 ± 1.29 1.99 ± 1.27 0.988 
 
1.94 ±  0.32 2.02 ±  0.24 1.98 ± 0.29 0.607 
23:0 (tricosanoic acid) 0.31 ± 0.06  
0.31 ± 0.05 0.31 ± 0.06 0.935 
 
0.30 ± 0.07 0.32 ± 0.05 0.31 ± 0.05 0.576 
24:0 (lignoceric acid) 5.59 ± 0.75  
5.7 ± 0.84 5.46 ± 0.63 0.242 5.45 ± 0.83 5.73 ± 0.63 5.54 ± 0.81 0.583 
      
Monounsaturated       
16:1n-9 (hypogeic acid) 0.11 ± 0.03  
0.11 ± 0.01 0.11 ± 0.04 0.524 
 
0.11 ± 0.04 0.11 ± 0.03 0.11 ± 0.01 0.934 
16:1n-7 (palmitoleic acid) 0.24 ± 0.07  
0.24 ± 0.07 0.23 ± 0.07 0.561 
 
0.23 ± 0.08 0.23 ± 0.08 0.25 ± 0.05 0.795 
18:1n-9 (oleic acid) 11.09 ± 0.94  
11.16 ± 0.89 11.02 ±  1.01 0.569 11.19 ± 1.16 10.95 ± 0.91 11.18 ± 0.83 0.719 
18:1n-7 (vaccenic acid) 1.08 ± 0.11  
1.07 ± 0.10 1.09 ± 0.12 0.392 1.02 ± 0.07
a
 1.08 ± 0.11
ab
 1.12 ± 0.10
b
 0.036 
20:1n-9 (eicosenoic acid) 0.20 ± 0.08  
0.21 ± 0.10 0.19 ± 0.02 0.474 0.18 ± 0.02 0.19 ± 0.02 0.22 ± 0.12 0.361 
24:1n-9 (nervonic acid) 5.73 ± 0.92  
5.9 ± 1.14 5.56 ±  0.56 0.179 5.34 ± 1.11 6.02 ± 0.60 5.70  ± 0.99 0.240 
 
    
  
 
 
 
 n-6 Polyunsaturated     
  
 
 
 
 18:2n-6 (linoleic acid) 10.70 ± 1.08  
10.72 ± 1.06 10.68 ± 1.13 0.916 10.49 ± 0.77 10.78 ± 1.13 10.78 ± 1.24 0.795 
18:3n-6 (-linolenic acid) 0.06 ± 0.02  
0.06 ± 0.02 0.06 ± 0.02 0.193 0.06 ± 0.02
a
 0.06 ± 0.02
a
 0.07 ± 0.02
b
 0.027 
20:2n-6 (eicosadienoic acid) 0.23 ± 0.07  
0.24 ± 0.09 0.22 ± 0.05 0.222 0.20 ± 0.06   0.23 ± 0.03 0.26 ± 0.10 0.138 
20:3n-6 (dihomo-γ-linolenic acid) 1.91 ± 0.38  
2.01 ± 0.46
a
 1.81 ± 0.24
b
 0.050 1.75 ± 0.26 1.95 ± 0.37 1.99 ± 0.44 0.137 
20:4n-6 (arachidonic acid) 11.05 ± 1.14  
10.89 ± 1.29 11.23 ± 0.95 0.270 11.43 ± 1.23 10.84 ± 0.86 11.01 ± 1.33 0.446 
22:4n-6 (adrenic acid) 1.93 ± 0.49  
1.92 ± 0.53 1.94 ± 0.44 0.867 
 
1.9 ± 0.53 1.76 ± 0.27 2.14 ± 0.58 0.114 
Total PUFA n-6 25.89 ± 1.58  26.15 ± 1.37 
25.85 ± 1.50 0.815 
 
25.83 ± 1.69 25.62 ± 1.58 26.25 ± 1.51 0.457 
Total LC-PUFAs n-6 14.90 ± 1.46  15.07 ± 1.19 
14.82 ± 1.64 0.681 15.08 ± 1.65 14.56 ± 1.16 15.14 ± 1.59 0.392 
      
n-3 Polyunsaturated       
18:3n-3 (α-linolenic acid) 0.09 ± 0.04  
0.09 ± 0.02 0.09 ± 0.02 0.827 
 
0.09 ± 0.04 0.09 ± 0.04 0.10 ± 0.03 0.291 
20:5n-3 (eicosapentaenoic acid) 0.36 ± 0.21  
0.38 ± 0.21 0.33 ± 0.22 0.402 
 
0.37 ± 0.29 0.35 ± 0.22 0.36 ± 0.12 0.988 
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22:5n-3 (docosapentaenoic acid) 1.10 ± 0.20  
1.13 ± 0.21 1.07 ± 0.17 0.207 1.08 ± 0.20 1.04 ± 0.19 1.18 ± 0.19 0.130 
22:6n-3 (docosahexaenoic acid) 3.40 ± 0.89  
3.41 ± 0.96 3.38 ± 0.82 0.888 3.43 ± 0.67 3.49 ± 1.05 3.26 ± 0.86 0.781 
Total PUFAs n-3 4.95 ± 1.17  
4.68 ± 0.63 5.02 ± 1.21 0.632 
 
4.98 ± 0.99 4.97 ± 1.39 4.90 ± 1.06 0.976 
Total LC-PUFAs n-3 4.86 ± 1.17   4.59 ± 0.63 4.93 ± 1.21 0.637   4.89 ± 0.99 4.88 ± 1.39 4.80 ± 1.06 0.970 
Notes: FH, familiar hypercholesterolemia; FCHL, familiar combined hyperlipidemia; PHC, polygenic hypercholesterolemia; TC, total 
cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; SFAs, saturated fatty 
acids; MUFAs, monounsaturated fatty acids; PUFAs, polyunsaturated fatty acids; LC-PUFAs, long chain polyunsaturated fatty acids (C ≥20, 
double bonds ≥ 3); omega-3 index, sum of EPA + DHA. Values are reported as mean ± SD. 
a,b
 Data with different letters are significantly 
different (p<0.05). 
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Table 3. Correlation between RBC phospholipid FAs and serum lipid concentrations (n= 54)  
RBC phospholipid fatty acids 
Serum Lipids 
TC HDL-C LDL-C TG HDL/LDL HDL/TG 
Total SFAs 0.095 -0.001 0.095 -0.077 -0.051 0.022 
Total MUFAs -0.290* -0.138 -0.274 0.371* 0.064 -0.308* 
Total PUFAs 0.020 0.072 0.021 -0.137 0.030 0.161 
MUFAs/SFAs ratio -0.208 -0.057 -0.210 0.262 0.073 -0.180 
PUFAs/SFAs ratio -0.025 0.029 -0.015 -0.058 0.021 0.084 
Total PUFAs n-3 0.104 -0.155 0.151 -0.068 -0.200 0.011 
Total PUFAs n-6 0.023 0.275* -0.028 -0.155 0.198 0.250 
PUFAs n-3/n-6 0.085 -0.220 0.151 -0.039 -0.231 -0.043 
Total LC-PUFAs n-3 0.105 -0.168 0.159 -0.064 -0.213 0.000 
Total LC-PUFAs n-6 0.174 0.207 0.120 -0.197 0.063 0.243 
LC-PUFAs n-3/n-6 -0.020 -0.229 0.059 0.006 -0.181 -0.080 
Omega-3 index 0.085 -0.203 0.160 -0.080 -0.233 -0.006 
Notes: TC, total cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; SFAs, 
saturated fatty acids; MUFAs monounsaturated fatty acids; PUFAs, polyunsaturated fatty acids; LC-PUFAs, long chain polyunsaturated fatty 
acids; omega-3 index, sum of EPA + DHA. *Statistical significance after Kendall and Spearman correlations for multiple comparisons (p<0.05). 
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Table 4. Correlation between dietary factors, RBC phospholipid FAs and serum lipids (n= 23)  
  Dietary factors 
Energy Protein Carbohydrate Total Fat SFAs MUFAs PUFAs PUFAs n-3  PUFAs n-6  Cholesterol Fiber 
Serum lipids                       
TC -0.265 -0.202 0.302 -0.204 -0.196 -0.221 -0.376 0.011 -0.083 -0.386 -0.210 
HDL-C -0.381 -0.126 0.163 -0.149 0.118 -0.102 -0.034 -0.087 -0.182 -0.254 -0.203 
TG -0.013 -0.101 -0.210 0.249 0.402 0.123 0.181 -0.007 0.099 0.180 0.104 
LDL-C -0.219 -0.243 0.187 -0.079 -0.147 -0.118 -0.339 0.204 -0.027 -0.280 -0.214 
HDL/LDL ratio -0.252 0.012 -0.012 -0.049 0.167 0.017 0.147 -0.081 -0.113 -0.061 -0.074 
HDL/TG ratio -0.289 -0.054 0.282 -0.289 -0.194 -0.147 -0.154 -0.010 -0.145 -0.277 -0.196 
 
           RBC phospholipid FAs 
Total SFAs -0.145 -0.108 0.150 -0.096 -0.297 -0.105 -0.010 -0.350 0.083 0.265 -0.235 
Total MUFAs 0.103 -0.137 -0.142 0.123 0.547 0.292 0.409 0.265 0.282 0.360 0.493 
Total PUFAs -0.059 0.174 -0.044 0.049 0.081 -0.047 -0.203 0.277 -0.216 -0.485 -0.012 
MUFAs/SFAs ratio 0.193 -0.056 -0.150 0.123 0.504 0.271 0.324 0.340 0.212 0.088 0.525* 
PUFAs/SFAs ratio 0.072 0.146 -0.093 0.069 0.164 0.027 -0.108 0.321 -0.128 -0.407 0.131 
Total PUFAs n-3 0.360 0.434 -0.397 0.181 -0.039 0.027 0.017 0.105 0.039 0.137 0.135 
Total PUFAs n-6 -0.164 -0.105 0.115 0.029 -0.076 -0.054 -0.282 0.201 -0.243 -0.762* -0.245 
PUFAs n-3/n-6 0.363 0.429 -0.409 0.167 -0.059 0.010 0.029 0.078 0.049 0.260 0.150 
Total LC-PUFAs n-3 0.360 0.434 -0.397 0.181 -0.039 0.027 0.017 0.105 0.039 0.137 0.135 
Total LC-PUFAs n-6 0.002 0.071 -0.201 0.118 0.108 0.051 -0.108 0.225 -0.157 -0.522* -0.142 
LC-PUFAs n-3/n-6 0.368 0.463 -0.390 0.135 -0.083 -0.034 0.007 0.020 0.034 0.390 0.176 
Omega-3 index 0.358 0.441 -0.350 0.127 -0.076 -0.032 -0.010 0.081 0.029 0.265 0.154 
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Notes: TC, total cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; SFAs, 
saturated fatty acids; MUFAs monounsaturated fatty acids; PUFAs, polyunsaturated fatty acids; LC-PUFAs, long chain polyunsaturated fatty 
acids; omega-3 index, sum of EPA + DHA. *Statistical significance after Kendall and Spearman correlations for multiple comparisons (p<0.05). 
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